αβINTEGRIN ANTAGONISTS AND USE THEREOF FOR TREATING FIBROSIS

A compound of formula (I)being 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof. Соединение формулы (I)представляющее собой 4-(3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3...

Full description

Saved in:
Bibliographic Details
Main Authors PRITCHARD John, Martin, ANDERSON Niall, Andrew, HANCOCK Ashley, Paul, REDMOND Joanna, Mary, CAMPBELL-CRAWFORD Matthew, Howard, James
Format Patent
LanguageEnglish
Russian
Published 31.01.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A compound of formula (I)being 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof. Соединение формулы (I)представляющее собой 4-(3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановую кислоту, или его соль.
Bibliography:Application Number: EA20170090715